Relationship between the pain severity, use of non-steroidal anti-inflammatory drugs and blood pressure in elective large joint arthroplasty of the lower extremities

Cover Page

Cite item

Full Text

Abstract

Aim. To evaluate the changes in blood pressure (BP), the severity of pain syndrome and non-steroidal anti-inflammatory drugs (NSAIDs) use patterns in patients hospitalized for elective arthroplasty of large joints of the lower extremities during the postoperative period.

Materials and methods. This study included 374 patients. In all patients, medical history, antihypertensive therapy and history of NSAIDs usage were collected, BP was measured, and the severity of pain was assessed via a 10-point scale before surgery, as well as 1 and 3 months after arthroplasty.

Results. The study included 132 (35.3%) males and 242 (64.7%) females. Among these, 289 (77.3%) patients had hypertension [grade 1 – 35 patients, grade 2 – 136 patients, grade 3 – 118 (25.0%) patients]; 280 (74.9%) patients were taking NSAIDs (121 – daily, 135 – 2–3 times per week). The median pain severity before surgery was 8 points [7; 9], 1 month after surgery – 2 points [1; 4], 3 months after surgery – 1 point [0; 3]. At 1 month after arthroplasty, 23 (7.9%) patients reported a decrease in BP. In 17 (5.9%) patients, correction of previously prescribed antihypertensive therapy with a decrease in drug doses was required. At 1 month after arthroplasty, 256 patients discontinued NSAIDs. The analysis of the relationship between the severity of pain, NSAIDs use and the level of BP revealed a significant effect of pain syndrome (p<0.0001) and the use of NSAIDs (p=0.014).

Conclusion. In the population of patients with elective arthroplasty of large joints of the lower extremities, a significant incidence of hypertension and a high prevalence of NSAIDs use are noted. During the postoperative period, a significant trend towards a decrease in the severity of pain was found, as well as the relationship of pain and NSAIDs with a decrease in BP.

About the authors

Elena A. Okisheva

Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: e.okisheva@gmail.com
ORCID iD: 0000-0003-2977-7203

Assistant at the Department of Faculty Therapy No. 1

Russian Federation, Moscow

Olga Iu. Mironova

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-5820-1759

Doctor of Medical Sciences, Professor of the Department of Faculty Therapy No. 1

Russian Federation, Moscow

Maria V. Berdysheva

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-3393-6863

student

Russian Federation, Moscow

Evgenia S. Pyatigorets

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0000-0003-2296-3900

student

Russian Federation, Moscow

Natalya P. Krivova

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0009-0002-0555-8831

student

Russian Federation, Moscow

Anna A. Kurnosova

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0009-0002-0555-9404

student

Russian Federation, Moscow

Mikhail P. Elizarov

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-4811-5718

traumatologist-orthopedist Clinics of traumatology, orthopedics and joint pathology

Russian Federation, Moscow

Sergey M. Smetanin

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-8607-4347

traumatologist-orthopedist Clinics of traumatology, orthopedics and joint pathology

Russian Federation, Moscow

Alexey V. Lychagin

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-2202-8149

Doctor of Medical Sciences, Professor, Head of Department. traumatology, orthopedics and disaster surgery

Russian Federation, Moscow

Victor V. Fomin

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-2682-4417

member-corr. RAS, Doctor of Medical Sciences, Professor, Vice-Rector for Innovation and Clinical Activities, Head of Department. Faculty Therapy No. 1

Russian Federation, Moscow

References

  1. Алексеева Л.И., Таскина Е.А., Кашеварова Н.Г. Остеоартрит: эпидемиология, классификация, факторы риска и прогрессирования, клиника, диагностика, лечение. Современная ревматология. 2019;13(2):9-21 [Alekseeva LI, Taskina EA, Kashevarova NG. Osteoarthritis: epidemiology, classification, risk factors, and progression, clinical presentation, diagnosis, and treatment. Modern Rheumatology Journal. 2019;13(2):9-21 (in Russian)]. doi: 10.14412/1996-7012-2019-2-9-21
  2. Портянникова О.О., Цвингер С.М., Говорин А.В., Романова Е.Н. Анализ распространенности и факторов риска развития остеоартрита в популяции. Современная ревматология. 2019;13(2):105-11 [Portyannikova OO, Tsvinger SM, Govorin AV, Romanova EN. Analysis of the prevalence and risk factors of osteoarthritis in a population. Modern Rheumatology Journal. 2019;13(2):105-11 (in Russian)]. doi: 10.14412/1996-7012-2019-2-105-111
  3. Fernandes GS, Valdes AM. Cardiovascular disease and osteoarthritis: common pathways and patient outcomes. Eur J Clin Invest. 2015;45(4):405-14. doi: 10.1111/eci.12413
  4. Reynolds CA, Minic Z. Chronic Pain-Associated Cardiovascular Disease: The Role of Sympathetic Nerve Activity. Int J Mol Sci. 2023;24(6):5378. doi: 10.3390/ijms24065378.
  5. Saccò M, Meschi M, Regolisti G, et al. The relationship between blood pressure and pain. J Clin Hypertens (Greenwich). 2013;15(8):600-5. doi: 10.1111/jch.12145.
  6. Fayaz A, Ayis S, Panesar SS, et al. Assessing the relationship between chronic pain and cardiovascular disease: A systematic review and meta-analysis. Scand J Pain. 2016;13(1):76-90. doi: 10.1016/j.sjpain.2016.06.005
  7. Каратеев А.Е. Дестабилизация артериальной гипертензии как осложнение терапии нестероидными противовоспалительными препаратами: значение проблемы. Современная ревматология. 2018;12(2):64-72 [Karateev AE. Destabilized hypertension as a complication of therapy with nonsteroidal anti-inflammatory drugs: the importance of the problem. Modern Rheumatology Journal. 2018;12(2):64-72 (in Russian)]. doi: 10.14412/1996-7012-2018-2-64-72
  8. Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med. 2016;375(26):2519-29. doi: 10.1056/NEJMoa1611593
  9. MacIntyre IM, Turtle EJ, Farrah TE, et al. Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial. Circulation. 2022;145(6):416-23. doi: 10.1161/CIRCULATIONAHA.121.056015
  10. Fournier JP, Sommet A, Bourrel R, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study. Eur J Clin Pharmacol. 2012;68(11):1533-40. doi: 10.1007/s00228-012-1283-9
  11. Муратов К.М., Ших Е.В., Лапидус Н.И., Сизова Ж.М. Артериальная гипертония и нестероидные противовоспалительные препараты: тактика ведения пациентов с учетом взаимодействия лекарственных средств. Медицинский совет. 2021;(4):258-64 [Muratov KM, Shikh EV, Lapidus NI, Sizova ZhM. Arterial hypertension and non-steroidal anti-inflammatory drugs: patient management tactics taking into account drug interactions. Meditsinskiy Sovet. 2021;(4):258-64 (in Russian)]. doi: 10.21518/2079-701X-2021-4-258-264
  12. Каратеев А.Е., Насонов Е.Л., Ивашкин В.Т. и др.; Ассоциация ревматологов России, Российское общество по изучению боли, Российская гастроэнтерологическая ассоциация, Российское научное медицинское общество терапевтов, Ассоциация травматологов-ортопедов России, Российская ассоциация паллиативной медицины. Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации. Научно-практическая ревматология. 2018;56(прил. 1):1-29 [Karateev AE, Nasonov EL, Ivashkin VT, et al; Association of Rheumatologists of Russian Society for the Study of Painn Gastroenterology Associationn Scientific Medical Society of Therapists, Association of Traumatologists and Orthopedists of Russian Association of Palliative Medicine. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines. Rheumatology Science and Practice. 2018;56(Suppl. 1):1-29 (in Russian)]. doi: 10.14412/1995-4484-2018-1-29
  13. Walker C, Biasucci LM. Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited. Postgrad Med. 2018;130(1):55-71. doi: 10.1080/00325481.2018.1412799
  14. Arfè A, Scotti L, Varas-Lorenzo C, et al. Safety of Non-steroidal Anti-inflammatory Drugs (SOS) Project Consortium. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ. 2016;354:i4857. doi: 10.1136/bmj.i4857
  15. Тарловская Е.И., Михайлова Ю.В. Хроническая сердечная недостаточность и частота приема нестероидных противовоспалительных средств: возможные риски по данным локального регистра. Российский кардиологический журнал. 2020;25(1):3677 [Tarlovskaya EI, Mikhailova YuV. Chronic heart failure and the frequency of taking nonsteroidal anti-inflammatory drugs: a register-based study on the possible risks. Russian Journal of Cardiology. 2020;25(1):3677 (in Russian)].Тарловская Е.И., Михайлова Ю.В. Хроническая сердечная недостаточность и частота приема нестероидных противовоспалительных средств: возможные риски по данным локального регистра. Российский кардиологический журнал. 2020;25(1):3677 [Tarlovskaya EI, Mikhailova YuV. Chronic heart failure and the frequency of taking nonsteroidal anti-inflammatory drugs: a register-based study on the possible risks. Russian Journal of Cardiology. 2020;25(1):3677 (in Russian)]. doi: 10.15829/1560-4071-2020-1-3677

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Severity of pain syndrome: a – before surgery; b – 1 month; c – 3 months; d – after arthroplasty and overall trend.

Download (149KB)
3. Fig. 2. Non-steroidal anti-inflammatory drugs usage: a – before surgery; b – 1 month; с – 3 months after arthroplasty (0 – no, 1 – every day, 2 – 2–3 times per week, 3 – 1 time per week or less frequently).

Download (82KB)

Copyright (c) 2023 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies